Clinical Trials on Whole Body Protein Metabolism

Total 8770 results

University of Calgary
Natural Sciences and Engineering Research Council, Canada

Withdrawn

Metabolic and Genetic Impacts of Energy Drinks in Youth

Pediatric Obesity | Glucose Intolerance | Health Behavior | Nutrition | Caffeine | Pediatric | Metabolism Disorder, Glucose

Canada
Mahidol University

Unknown

Effect of a Meal Replacement on Weight Loss Obesity Patients With Metabolic Syndrome (SlimWell)

Abdominal Obesity-Metabolic Syndrome

Thailand
Federico II University

Recruiting

The UFO (Ultra Processed Foods in Obesity) Project (UFO Project)

Metabolic Syndrome | Obesity, Morbid

Italy
University College, London
University College London Hospitals

Active, not recruiting

A Study Comparing the Health Effects of Two Diets Following UK Dietary Guidance in People Living With Overweight or Obesity (UPDATE)

Obesity | Overweight | Cardiometabolic Syndrome

United Kingdom
Griffin Hospital
California Walnut Commission

Completed

Effects of Walnuts on Endothelial Function in Overweight Adults With at Least One Factor of Metabolic Syndrome (Walnut2)

Metabolic Syndrome

United States
Laval University
Ministry of Agriculture, Fisheries and Food, Quebec; innoVactiv Inc.

Completed

Brown Seaweed Extract on Glycemic Control and Body Weight (Algues)

Insulin Resistance | PreDiabetes

Canada
Maastricht University Medical Center

Completed

The Effect of Olive Leaf Extract Administration on Cardiovascular Health

Overweight and Obesity | Elevated Cholesterol

Netherlands
Novo Nordisk A/S

Completed

Effect and Safety of Liraglutide 3.0 mg as an Adjunct to Intensive Behaviour Therapy for Obesity in a Non-specialist Setting (SCALE™ IBT)

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Awareness, Care & Treatment in Obesity Management (ACTION) Study (ACTION)

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Awareness, Care and Treatment in Obesity Management

Obesity | Metabolism and Nutrition Disorder

Canada
Novo Nordisk A/S

Completed

Investigation of Single Ascending Doses of NNC9204-1706 in Male Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Combination With Liraglutide in Male and Female Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

Investigation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of NNC0174-0833 in Subjects With Obesity or Overweight

Obesity | Metabolism and Nutrition Disorder

United States
University of Copenhagen
Danish Agriculture and Food Council

Completed

Acute Effects of Dairy and Meat Proteins on Bone Metabolism and Metabolic Profile (MEDA)

Obesity | Bone Metabolism

Denmark
University of North Carolina, Chapel Hill
Michigan Center for Diabetes Translational Research

Completed

Adaptation of a Digital Weight Loss Intervention Promoting Self-regulation for Use in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Overweight and Obesity

United States
Chiara Rafanelli

Completed

Promoting Weight Loss and Stress Reduction in Overweight and Obese Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Overweight and Obesity

Italy
Levenson, David I., M.D.

Completed

Efficacy of Self-hypnosis for Weight Loss in Type 2 Diabetics

Obesity | Diabetes Mellitus, Type 2 | Weight Reduction
Loma Linda University
Lifestyle Center of America

Completed

A Very High Fiber Diet Versus a Low-carbohydrate Diet for Weight Loss

Obesity | Type 2 Diabetes

United States
University Hospital Tuebingen
Medical University of Vienna; University of Bern; CenTrial GmbH

Terminated

Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine

Obesity | Diabetes

Austria, Germany, Switzerland
Radboud University Medical Center

Unknown

Determinants of Insulin-induced Weight Gain in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus | Weight Gain

Netherlands
The University of Western Australia

Completed

Effect of Abdominal Obesity on Lipoprotein Metabolism

Obesity | Insulin Resistance | Dyslipidemia

Australia
Texas Tech University
EHP Labs

Completed

Chronic Thermogenic Dietary Supplement Consumption

Body Weight Changes | Body Composition Changes | Anthropometric Changes | Metabolism Changes | Hemodynamic Changes

United States
University of Miami

Withdrawn

Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat

Obesity | Overweight | Monoclonal Gammopathies
Daewoong Pharmaceutical Co. LTD.

Not yet recruiting

Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus
Arkansas Children's Hospital Research Institute
Cargill

Recruiting

The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)

Microbial Colonization | Weight Gain | Adiposity | Insulin Sensitivity

United States
University Hospital Center of Martinique

Recruiting

Role NLRP3 Inflammasome in Weight Loss Following Sleeve Gastrectomy in Morbidly Obese Patients (BARIAMITRI)

Obesity-Associated Insulin Resistance | Obesity Morbid

Martinique
Washington University School of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Active, not recruiting

Weight Loss-Independent Metabolic Effects of Roux-En-Y Gastric Bypass in Diabetes (RBD-T2D)

Obesity | Type 2 Diabetes

United States
University of Alabama at Birmingham
General Mills

Completed

Development of an Adaptive Treatment for Weight Loss in People With Prediabetes

Obesity | PreDiabetes

United States
Stanford University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

Weight Loss | PreDiabetes

United States
The University of Hong Kong

Active, not recruiting

A Community-based Weight Loss Programme for Chinese Overweight Adults With Pre-diabetes

Pre-diabetes

Hong Kong
Wake Forest University Health Sciences
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Medifast...

Completed

Valued EpiGenetic Glycemic ImprovEments Through Weight Loss (VEGGIE)

Obesity | Pre-diabetes

United States
University of Pennsylvania
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); New... and other collaborators

Completed

Testing the Influence of Different Sugary Drink Warning Label Designs

Obesity | Weight Gain | Diabetes Type 2

United States
AstraZeneca
Eli Lilly and Company

Completed

A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients

Type 2 Diabetes

United Kingdom
Boston Medical Center

Completed

Use of MCT Oil for Enhancement of Weight Loss and Glycemic Control in Obese Diabetic Patients

Obesity | Type 2 Diabetes Mellitus

United States
Rigshospitalet, Denmark

Completed

Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients (Le-Na)

Weight Gain | Diabetes Type 2

Denmark
Northwestern University
Takeda

Completed

Prevention of Weight Gain in Adult Patients With Type 2 Diabetes Treated With Pioglitazone

Obesity | Type 2 Diabetes

United States
University of Calgary
Stewart Diabetes Education Fund

Completed

Use of a Portion Control Food Tool to Induce Weight Loss in Obese Type 2 Diabetics.

Obesity | Type 2 Diabetes Mellitus

Canada
Novo Nordisk A/S

Completed

A Research Study Looking at a New Study Medicine (NNC0194-0499) for Weight Control in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0194-0499 in Male Subjects With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Completed

A Trial Investigating Safety, Tolerability, PK and PD for Multiple Doses of NNC9204-0530 in Male and Female Subjects Being Overweight or With Obesity

Obesity | Metabolism and Nutrition Disorder

United States
Novo Nordisk A/S

Terminated

A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers

Obesity | Metabolism and Nutrition Disorder

United States
Vanderbilt University Medical Center

Active, not recruiting

Role of Sympathetic Vasoconstriction on Insulin-Mediated Microvascular Recruitment and Glucose Uptake in Obesity

Healthy | Obesity | Insulin Resistance

United States
Patrice D. Cani
Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Completed

Evaluation of the Effects Associated With the Administration of Akkermansia Muciniphila on Parameters of Metabolic Syndrome (Microbes4U)

Glucose Metabolism Disorders | Obesity | Dyslipidemias | Metabolic Syndrome x

Belgium
Pfizer

Completed

Multiple Dose Safety Toelrability, Pharmacokinetics and Midazolam Interaction In Healthy Overweight And Obese Subjects

Glucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus

United States
20Lighter

Recruiting

Evaluation of Body Composition Improvement With Visceral Adiposity-Focused Anti-Obesity Telehealth Program

Cardiovascular Diseases | Obesity | Metabolic Syndrome | Metabolic Disease

United States
VA Office of Research and Development

Terminated

Metabolic Effects of Natriuretic Peptide Hormones (MENP)

Obesity | Metabolism | Cardiovascular Physiological Phenomena

United States
Novo Nordisk A/S

Completed

Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity (STEP 4)

Obesity | Metabolism and Nutrition Disorder

United States, Israel, Spain, Netherlands, Sweden, Switzerland, South Africa, Denmark, Portugal, Ukraine
Novo Nordisk A/S

Completed

Research Study Investigating Study Medicine (NNC9204-1177) for Weight Management in People With Overweight or Obesity

Obesity | Metabolism and Nutrition Disorder

United States

Clinical Trials on Whole Body Protein Metabolism

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations